Results 101 to 109 of about 2,156 (109)

NAFLD, NASH and liver cancer

Nature Reviews Gastroenterology and Hepatology, 2013
Gregory A Michelotti, Anna Mae Diehl
exaly  

Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials

Hepatology, 2018
Cyrielle Caussy, Scott B Reeder, Claude B Sirlin   +2 more
exaly  

Lipotoxicity and the gut-liver axis in NASH pathogenesis

Journal of Hepatology, 2018
Fabio Marra, Gianluca Svegliati-Baroni
exaly  

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

Journal of Hepatology, 2017
Hannes Hagström, Patrik Nasr, Mattias Ekstedt   +2 more
exaly  

Current and future pharmacological therapies for NAFLD/NASH

Journal of Gastroenterology, 2017
Yoshio Sumida
exaly  

From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

Nature Reviews Gastroenterology and Hepatology, 2013
Alexander Wree, Ali Canbay, Hal M Hoffman   +2 more
exaly  

Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution

Nature Metabolism, 2019
Joel T Haas, Luisa Vonghia, Denis A Mogilenko   +2 more
exaly  

Método para determinar equilibrios de Nash en juegos bimatriciales m × 3

Miscelánea Matemática de la Sociedad Matemática Mexicana
openaire   +1 more source

Juegos normales competitivos basados en equilibrios de Nash: su relación con la estrategia

Gabriel Turbay, Félix Oscar Socorro Márquez, Giovanni Efraín Reyes Ortiz   +2 more
openaire   +1 more source